
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[GILD] Gilead Sciences, Inc. - Investing Cash Flow / Sales
Data updated 2024-Mar-24 (Sunday)Note: Detailed Statistics for Investing Cash Flow / Sales in Cashflow Statement for Gilead Sciences, Inc. [NASDAQ:GILD] with frequency distribution chart that analyze trends & history . Investing Cash Flow / Sales or Revenue is expressed as a % for period. View Cashflow Statement for broader context
Share
Quarterly Investing Cash Flow / Sales values for Gilead Sciences, Inc. are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Investing Cash Flow / Sales | -10.2% | -3.3% | -7.3% | -13.1% | -5.1% | -10.2% |
Sequential Quarter Growth | -213.5% | +55.5% | +43.8% | -154.4% | +49.7% | -105.4% |
Quarter-on Quarter Growth | -99.2% | +68.0% | -47.8% | +19.9% | -33.6% | -224.5% |
Annual Investing Cash Flow / Sales values for Gilead Sciences, Inc. are rounded to enhance readability
2023-Dec | 2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | |
---|---|---|---|---|---|---|
Investing Cash Flow / Sales | -8.4% | -9.1% | -9.0% | -11.4% | -59.3% | -35.0% |
Year-on-Year Growth | +8.2% | -0.7% | +21.0% | +80.7% | -69.4% | -154.2% |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly Investing Cash Flow / Sales values from 2008-Jun-30 grouped into buckets. Latest Investing Cash Flow / Sales value is -10.2 as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for Gilead Sciences, Inc. mapped with quarterly Investing Cash Flow / Sales values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Investing Cash Flow / Sales above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Gilead Sciences, Inc. with subsequent post-earnings performance given Investing Cash Flow / Sales values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Investing Cash Flow / Sales - Low | 71% | 29% |
Investing Cash Flow / Sales - Medium | 43% | 57% |
Investing Cash Flow / Sales - High | 35% | 65% |
Investing Cash Flow / Sales (Sequential growth %) - Low | 29% | 71% |
Investing Cash Flow / Sales (Sequential growth %) - Medium | 45% | 55% |
Investing Cash Flow / Sales (Sequential growth %) - High | 75% | 25% |
Investing Cash Flow / Sales (QoQ growth %) - Low | 45% | 55% |
Investing Cash Flow / Sales (QoQ growth %) - Medium | 58% | 42% |
Investing Cash Flow / Sales (QoQ growth %) - High | 42% | 58% |
Related to Gilead Sciences, Inc.
Information for Gilead Sciences, Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-02 on Google
SEC Reports : Quarterly reports around 2025-May-02 on SEC Edgar
Compare Gilead Sciences, Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Gilead Sciences, Inc.
Industry : Biotechnology industry performance which includes Gilead Sciences, Inc.